Ligand Pharmaceuticals LGND Other Investments
Other Investments at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherInvestments.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's other investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's other investments?
- Ligand Pharmaceuticals (LGND) reported other investments of $87.77M in Q1 2026.
- How has Ligand Pharmaceuticals's other investments changed year-over-year?
- Ligand Pharmaceuticals's other investments increased by 704.6% year-over-year, from $10.91M to $87.77M.
- What is the long-term trend for Ligand Pharmaceuticals's other investments?
- Over 3 years (2022 to 2025), Ligand Pharmaceuticals's other investments has grown at a 243.4% compound annual growth rate (CAGR), from $3M to $121.45M.
- What does other investments mean?
- This category includes miscellaneous long-term investments that do not fall under standard classifications like marketable securities or equity method investments. It reflects the company's strategic deployment of capital into non-core or specialized financial interests. Investors use this to understand the breadth of the company's investment portfolio and potential for non-operating income.